Bilhim, Tiago https://orcid.org/0000-0003-3044-8474
Article History
Received: 13 July 2025
Accepted: 12 September 2025
First Online: 25 September 2025
Change Date: 6 October 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00270-025-04233-1
Declarations
:
: Tiago Bilhim has received speaker fees for Philips Medical, Cook Medical, Terumo, Merit Medical, Guerbet and is a stockholder for EmbolX.
: Institutional review board approval, consent for publication, and informed consent were not needed for this Editorial.
Free to read: This content has been made available to all.